Shares of Charles River Laboratories International Inc. slipped 4.91% to $165.35 Thursday, on what proved to be an all-around ...

Goldman Sachs downgraded contract research organizations Icon Public Limited (NASDAQ:ICLR) and Charles River Laboratories ...

Learn more about whether Charles River Laboratories International, Inc. or Stevanato Group S.p.A. is a better investment ...

The 12-month price targets, analyzed by analysts, offer insights with an average target of $174.3, a high estimate of $190.00 ...

Charles River Laboratories’s shares have sunk to $173.44, producing a disappointing 15.7% loss while the S&P 500 was flat.

Charles River Labs (CRL – Research Report) received a Hold rating and price target from Goldman Sachs analyst Matthew Sykes today. The ...

Goldman Sachs analyst Matthew Sykes downgraded Charles River (CRL) to Neutral from Buy with a price target of $170, down from $190. While the ...

Proficio Capital Partners LLC acquired a new position in shares of Charles River Laboratories International, Inc. (NYSE:CRL – ...

Shares of Charles River Laboratories International Inc. CRL rose 1.10% to $176.94 Tuesday, on what proved to be an all-around ...

Research analysts at Zacks Research decreased their Q1 2025 earnings per share (EPS) estimates for Charles River Laboratories ...

Most readers would already be aware that Charles River Laboratories International's (NYSE:CRL) stock increased significantly by 15% over the past month. Given that stock prices are usually aligned ...

The stock's fall snapped a three-day winning streak.